Is HZNP stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Horizon Therapeutics had a stock price of $11.93. If you invested back then, your return now would be a profit of $104.37 per share or 874.85%
Yes, the average daily trading liquidity for Horizon Therapeutics is $269.61 million. You should therefore be able to get in and out of your positions relatively fast.
Horizon Therapeutics has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.49, the company's ability to pay off the debt is normal. Horizon Therapeutics has a good net profit margin of 14.37% and should have high tolerances against inflation.
We have calculated the inflation risk for Horizon Therapeutics to be low [0.4 out of 1]